HRAS and neoplasm: ERK1/2 are known to be key regulators in MAPK pathway, and it has been reported that H-RAS (G12V) activated MAPK pathway so that ERK1/2 contributed to p-DRP (S616) and mitochondrial fission, which then drove tumor growth in pancreatic cancer26.